These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
These 4 Measures Indicate That Merit Medical Systems (NASDAQ:MMSI) Is Using Debt Safely
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. Importantly, Merit Medical Systems, Inc. (NASDAQ:MMSI) does carry debt. But should shareholders be worried about its use of debt?
大衛·伊本說得好,他說:「波動性不是我們關心的風險。我們關心的是避免資本的永久損失。」因此,很明顯,當你考慮任何給定股票的風險時,你需要考慮債務,因爲過多的債務會使公司陷入困境。重要的是,Merit Medical Systems, Inc.(納斯達克股票代碼:MMSI)確實有債務。但是,股東是否應該擔心其債務的使用?
Why Does Debt Bring Risk?
爲什麼債務會帶來風險?
Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Of course, plenty of companies use debt to fund growth, without any negative consequences. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.
當企業無法輕易履行這些義務時,無論是通過自由現金流還是以誘人的價格籌集資金,債務和其他負債就會面臨風險。最終,如果公司無法履行償還債務的法律義務,股東可能一無所有地離開。儘管這種情況不太常見,但我們經常看到負債公司永久稀釋股東,因爲貸款人迫使他們以低價籌集資金。當然,許多公司使用債務爲增長提供資金,而不會產生任何負面後果。在考慮企業使用多少債務時,要做的第一件事是將其現金和債務放在一起考慮。
How Much Debt Does Merit Medical Systems Carry?
Merit 醫療系統揹負了多少債務?
You can click the graphic below for the historical numbers, but it shows that as of September 2024 Merit Medical Systems had US$750.5m of debt, an increase on US$286.1m, over one year. On the flip side, it has US$523.1m in cash leading to net debt of about US$227.4m.
你可以點擊下圖查看歷史數字,但它顯示,截至2024年9月,Merit Medical Systems在一年內有7.505億美元的債務,比2.861億美元有所增加。另一方面,它擁有5.231億美元的現金,淨負債約爲2.274億美元。
How Strong Is Merit Medical Systems' Balance Sheet?
Merit Medical Systems的資產負債表有多強?
According to the last reported balance sheet, Merit Medical Systems had liabilities of US$201.1m due within 12 months, and liabilities of US$853.6m due beyond 12 months. Offsetting this, it had US$523.1m in cash and US$213.3m in receivables that were due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by US$318.2m.
根據上次報告的資產負債表,Merit Medical Systems的負債爲2.01億美元,12個月以後到期的負債爲8.536億美元。與此相抵消的是,它有5.231億美元的現金和2.133億美元的應收賬款將在12個月內到期。因此,其負債超過其現金和(短期)應收賬款總額3.182億美元。
Since publicly traded Merit Medical Systems shares are worth a total of US$6.07b, it seems unlikely that this level of liabilities would be a major threat. However, we do think it is worth keeping an eye on its balance sheet strength, as it may change over time.
由於公開交易的Merit Medical Systems股票總價值爲60.7億美元,因此這種負債水平似乎不太可能構成重大威脅。但是,我們確實認爲值得關注其資產負債表的實力,因爲它可能會隨着時間的推移而發生變化。
In order to size up a company's debt relative to its earnings, we calculate its net debt divided by its earnings before interest, tax, depreciation, and amortization (EBITDA) and its earnings before interest and tax (EBIT) divided by its interest expense (its interest cover). Thus we consider debt relative to earnings both with and without depreciation and amortization expenses.
爲了擴大公司相對於收益的負債規模,我們計算其淨負債除以利息、稅項、折舊和攤銷前的收益(EBITDA),將其利息和稅前收益(EBIT)除以利息支出(利息保障)。因此,我們將債務與收益的關係考慮在內,包括和不包括折舊和攤銷費用。
Merit Medical Systems's net debt is only 0.91 times its EBITDA. And its EBIT covers its interest expense a whopping 31.8 times over. So you could argue it is no more threatened by its debt than an elephant is by a mouse. Another good sign is that Merit Medical Systems has been able to increase its EBIT by 21% in twelve months, making it easier to pay down debt. There's no doubt that we learn most about debt from the balance sheet. But ultimately the future profitability of the business will decide if Merit Medical Systems can strengthen its balance sheet over time. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.
Merit Medical Systems的淨負債僅爲息稅折舊攤銷前利潤的0.91倍。其息稅前利潤覆蓋了高達31.8倍的利息支出。因此,你可以爭辯說,它受到債務的威脅並不比大象受到老鼠的威脅更大。另一個好兆頭是,Merit Medical Systems能夠在十二個月內將其息稅前利潤提高21%,從而更容易償還債務。毫無疑問,我們從資產負債表中學到的關於債務的知識最多。但最終,該業務未來的盈利能力將決定Merit Medical Systems能否隨着時間的推移加強其資產負債表。因此,如果你想看看專業人士的想法,你可能會發現這份關於分析師利潤預測的免費報告很有趣。
But our final consideration is also important, because a company cannot pay debt with paper profits; it needs cold hard cash. So it's worth checking how much of that EBIT is backed by free cash flow. During the last three years, Merit Medical Systems generated free cash flow amounting to a very robust 83% of its EBIT, more than we'd expect. That puts it in a very strong position to pay down debt.
但是我們最終的考慮因素也很重要,因爲公司無法用紙面利潤來償還債務;它需要冷硬現金。因此,值得檢查一下該息稅前利潤中有多少是由自由現金流支持的。在過去三年中,Merit Medical Systems產生的自由現金流相當於其息稅前利潤的83%,超出了我們的預期。這使其在償還債務方面處於非常有利的地位。
Our View
我們的觀點
Merit Medical Systems's interest cover suggests it can handle its debt as easily as Cristiano Ronaldo could score a goal against an under 14's goalkeeper. And the good news does not stop there, as its conversion of EBIT to free cash flow also supports that impression! It's also worth noting that Merit Medical Systems is in the Medical Equipment industry, which is often considered to be quite defensive. We think Merit Medical Systems is no more beholden to its lenders, than the birds are to birdwatchers. For investing nerds like us its balance sheet is almost charming. We'd be very excited to see if Merit Medical Systems insiders have been snapping up shares. If you are too, then click on this link right now to take a (free) peek at our list of reported insider transactions.
Merit Medical Systems的利息保障表明,它可以像克里斯蒂亞諾·羅納爾多在對陣14歲以下的守門員的比賽中進球一樣輕鬆地處理債務。好消息不止於此,因爲它將息稅前利潤轉換爲自由現金流也支持了這種印象!還值得注意的是,Merit Medical Systems屬於醫療設備行業,人們通常認爲該行業具有很強的防禦性。我們認爲,Merit Medical Systems受貸款人的束縛並不比鳥類對觀鳥者的束縛。對於像我們這樣的投資書呆子來說,它的資產負債表幾乎是迷人的。看看Merit Medical Systems內部人士是否在搶購股票,我們會非常興奮。如果您也是,請立即點擊此鏈接,(免費)查看我們報告的內幕交易清單。
When all is said and done, sometimes its easier to focus on companies that don't even need debt. Readers can access a list of growth stocks with zero net debt 100% free, right now.
當一切都說完之後,有時更容易將注意力集中在甚至不需要債務的公司身上。讀者現在可以免費訪問淨負債爲零的成長型股票清單。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?擔心內容嗎?直接聯繫我們。或者,發送電子郵件給編輯組(網址爲)simplywallst.com。
Simply Wall St 的這篇文章本質上是籠統的。我們僅使用公正的方法提供基於歷史數據和分析師預測的評論,我們的文章並非旨在提供財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不會考慮最新的價格敏感型公司公告或定性材料。華爾街只是沒有持有上述任何股票的頭寸。